Shares of AstraZeneca (AZN) fall 3.3% in London trading as news that partner Targacept's (TRGT)...

|About: AstraZeneca Group plc (AZN)|By:, SA News Editor

Shares of AstraZeneca (AZN) fall 3.3% in London trading as news that partner Targacept's (TRGT) depression treatment failed to meet a goal adds to a string of misfires with its development pipeline. Analysts at Barclays Capital say that the buildup failures will prompt management to "reassess the likely return on investment from additional R&D investment and cut costs further."